SCHEMBL4905533

SCHEMBL4905533

CCN(c1nc(-c2ccc(C(F)(F)F)cc2)sc1C)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
HSP90AA1 P07900 1/20 0.42
MAPT P10636 1/20 0.42
CRHBP P24387 1/20 0.42
KMT2A Q03164 1/20 0.42
CRHR2 Q13324 1/20 0.42
GAA P10253 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 3/20 0.39
NPC1 O15118 1/20 0.39
PPARA Q07869 4/20 0.39
TSHR P16473 1/20 0.38
HDAC8 Q9BY41 2/20 0.37
RORC P51449 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4900703 0.92 KDM4E (0.41) KDM4EMEN1HSP90AA1MAPTCRHBP
SCHEMBL4906254 0.92 NR1I2 (0.40) KDM4EMEN1MAPTKMT2AGAA
SCHEMBL4906349 0.92 ALDH1A1 (0.50) KDM4EMEN1HSP90AA1MAPTCRHBP
SCHEMBL4907462 0.91 TRPM8 (0.43) KDM4EALDH1A1RORCTRPM8
SCHEMBL4900544 0.91 KDM4E (0.41) KDM4EMEN1HSP90AA1MAPTCRHBP
SCHEMBL4906968 0.90 PSEN1 (0.41) KDM4EMEN1MAPTKMT2AGAA
SCHEMBL4905594 0.90 TRPM8 (0.42) KDM4EMEN1HSP90AA1MAPTCRHBP
SCHEMBL4898098 0.90 ALDH1A1 (0.41) KDM4EMEN1MAPTKMT2AGAA
SCHEMBL4903085 0.90 GAA (0.40) KDM4EMEN1HSP90AA1MAPTCRHBP
SCHEMBL4906767 0.89 ALDH1A1 (0.44) KDM4EMEN1MAPTKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD KDM4E 3750/4885MEN1 4859/4885HSP90AA1 1154/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KDM4E 3834/4885MEN1 4855/4885HSP90AA1 1021/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD KDM4E 3834/4885MEN1 4855/4885HSP90AA1 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.